Medline Inc. - Class A common stock (MDLN)
39.12
-0.49 (-1.24%)
NASDAQ· Last Trade: Jun 30th, 1:38 PM EDT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 30, 2026
NEW YORK, NY - June 30, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via TheNewswire.com · June 30, 2026
NEW YORK, NY - June 29, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via TheNewswire.com · June 29, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 29, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 27, 2026
NEW YORK, NY - June 27, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via TheNewswire.com · June 27, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 26, 2026
NEW YORK, NY - June 26, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via TheNewswire.com · June 26, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 25, 2026
NEW YORK, NY - June 25, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via TheNewswire.com · June 25, 2026
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medline Industries, Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · June 23, 2026
NEW YORK, NY - June 20, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via TheNewswire.com · June 20, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 20, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 19, 2026
NEW YORK, NY - June 19, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via TheNewswire.com · June 19, 2026
NEW YORK, NY - June 18, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via NewMediaWire · June 18, 2026
NEW YORK, NY - June 18, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via TheNewswire.com · June 18, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 17, 2026
NEW YORK, NY - June 17, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via TheNewswire.com · June 17, 2026
NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Medline Industries, Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · June 16, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 16, 2026
NEW YORK, NY - June 16, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via TheNewswire.com · June 16, 2026
NEW YORK, NY - June 15, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via TheNewswire.com · June 15, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · June 15, 2026
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medline Inc. (“Medline” or “the Company”) (NASDAQ: MDLN) for violations of the securities laws.
By Schall Law · Via GlobeNewswire · June 10, 2026